Post by
SPCEO1 on Apr 26, 2021 10:22am
Magic Mushrooms
To again highlight the insanity that TH has failed to tap into, MindMed, a Canadian company hoping to develop drugs for legit purposes using LSD and similiar illegal drugs, is spiking higher because it is about to list on NASDAQ. It has a market cap now of US$1.5 billion compared to TH's US$325.
MindMed has one drug in phase 2A and some others in earlier stages of development.
It is hard to take when TH has so much more but cannot seem to get the interest that companies like MindMed get depsite having products generating revenue, a NASH phase III and a very, ery intriguing cancer with a highly unusual pre-clinical Fast Track designation and the backing of a leading investor specializing in cancer stocks. In this market, those aspects of TH should be creating a much, much higher valuation than what we currently have.
It needs to be fixed ASAP. It is unacceptable to see only TH being left behind.
Comment by
stephanedodier on Apr 26, 2021 10:42am
HAVN Life Sciences Inc (HAVN.V) have a market cap of $68M CND, not all of them have stratospheric value.
Comment by
SPCEO1 on Apr 26, 2021 11:08am
So many small caps I look at do not have the potential that TH has yet sell at much higher valuations. TH needs to figure out how to tap into that rather than finding the few, like the Vancouver traded HAVN, to justify TH's inability to be part of the bull market despite the impressive successes it has had in NASH and cancer.
Comment by
SPCEO1 on Apr 26, 2021 11:26am
Jsut did a quick tour of the MindMed website - they even have a section where you can purchase MindMed themed clothes, coffee mugs, etc. I am not sure TH needs that section on their new website, whenever that shows up, but it gives you an indication of how a company works to build a retail brand for its stock.
Comment by
qwerty22 on Apr 26, 2021 11:43am
Feels like your beating yourself up doing these sorts of comparisons. I don't believe THTX could ever have the exuberance that mushroom stocks have. There appeal is in large parts irrational, I don't think you can have a market strat that encourages that around THTX.
Comment by
SABBOBCAT on Apr 26, 2021 12:11pm
Buck, I believe that sentiment lagely shared. This is why I think that, baring some sort of change in strategy, the next year could be a slow one for us before an enventual buyout at 2bn. Sure great upside fot the short term holders, but a rough pill to swalloe for LT holders. It would leave a lot on the table for value in ternms of NASH and oncology.
Comment by
palinc2000 on Apr 26, 2021 1:09pm
What makes you think Dubuc is good with numbers?The Offering was under his responsibility and every aspect was a failure. 1- Pricing of the Units 2- Issuance of Warrants 3- Exercise Price of Warrants 4-Expiry date of Warrants 5-Share Placement in wrong Hands 6-Lack of preparedness etcccc I
Comment by
palinc2000 on Apr 30, 2021 12:02pm
I am reposting this because I feel that this weak link in managemenent needs be to fixed ASAP
Comment by
realitycheck4u on Apr 30, 2021 12:34pm
This post has been removed in accordance with Community Policy
Comment by
palinc2000 on Apr 30, 2021 12:41pm
If true that a US deal fell thru due a technicality then its even worst,,,,,,His job was to make it work,,,,The Board approved a deal that it was presented but the head negotiator had to be the CFO,,,
Comment by
jeffm34 on Apr 26, 2021 1:23pm
I think you have nailed the main problem. It's a closed minded business culture of "only we know best". They would rather fail miserably with their own ideas than admit they might benefit from outside advice or help. No one is held responsible for any mistakes.
Comment by
Bucknelly21 on Apr 26, 2021 1:40pm
I just don't see how it will change until we start voting people out...
Comment by
Sqidmandon on Apr 26, 2021 3:14pm
Not hard to take when you own it! I call it the Shroom Vroom! Now Therf....that's hard to take!